组织工程市场规模、份额、成长分析、按产品、按材料、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

2022年全球组织工程市场规模为37.5亿美元，从2023年的44.2亿美元成长到2031年的137.4亿美元，预测期（2024-2031）预计复合年增长率为15.23%。

组织工程市场正在迅速发展，以满足器官移植和组织再生的关键需求。传统的移植方法面临器官短缺和排斥等问题，增加了创新解决方案的需求。组织工程已成为一种可行的替代方案，并有望透过提供根据患者个体需求量身定制的生物工程组织和器官来改变各种疾病和损伤的治疗格局。包括心血管疾病和器官衰竭在内的慢性疾病的日益流行，成为市场成长的关键催化剂，因为组织工程提供了潜在的再生解决方案。然而，这个市场面临着巨大的投资需求的挑战，包括昂贵的实验室设备、研究材料和大规模临床试验，以及阻碍开发和核准过程的监管障碍。儘管存在这些障碍，干细胞研究和技术创新的进步为市场扩张提供了坚实的基础。未来的商机在于个人化医疗和再生医学领域，它们不仅有可能显着改善患者的治疗，而且有可能改变整个医疗保健领域。随着组织工程市场不断成熟，解决高开发成本和创新解决方案之间的平衡对于充分发挥其潜力至关重要。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 价格分析
• 价值链分析
• 供应链分析
• 技术分析
• 专利分析
• 监管环境
• 客户和购买标准分析

组织工程市场：副产品

• 市场概况
• 鹰架
  • 合成支架
  • 生物支架
  • 胶原蛋白蛋白支架
  • 水凝胶支架
  • 基于干细胞的支架
  • 其他基于生物材料的支架
• 组织移植
  • 同种异体移植
  • 自体移植
  • 合成移植物
  • 异种移植
• 其他产品

组织工程市场：依材料分类

• 市场概况
• 合成材料
• 生物来源材料

组织工程市场：依应用分类

• 市场概况
• 整形外科和肌肉骨骼疾病
• 皮肤科/创伤护理
• 牙科疾病
• 心血管疾病
• 其他用途

组织工程市场：依最终使用者分类

• 市场概况
• 医院
• 专科中心和诊所
• 门诊手术中心

组织工程市场规模：依地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Organogenesis Inc.
• AbbVie Inc.
• MiMedx Group, Inc.
• Johnson & Johnson Services, Inc.
• B. Braun SE
• NuVasive, Inc.
• WL Gore & Associates, Inc.
• Zimmer Biomet
• Collplant Biotechnologies Ltd.
• Sumitomo Pharma Co., Ltd.
• Regrow Biosciences Pvt. Ltd.
• Tecnoss SRL
• Integra Lifesciences
• Smith & Nephew Plc
• Baxter
• BD
• Teijin Limited
• Institut Straumann Ag
• Medtronic
• Stryker
• Terumo Corporation
• Zimmer Biomet
• TissueTech
• Matricel Gmbh
• Mallinckrodt
• Vericel Corporation
• Tegoscience
• Tissue Regenix

Global Tissue Engineering Market size was valued at USD 3.75 billion in 2022 and is poised to grow from USD 4.42 billion in 2023 to USD 13.74 billion by 2031, growing at a CAGR of 15.23% during the forecast period (2024-2031).

The tissue engineering market is rapidly evolving to meet the critical demand for organ transplantation and tissue regeneration. Traditional transplantation methods struggle with issues such as organ shortages and rejection, which has intensified the need for innovative solutions. Tissue engineering emerges as a viable alternative, offering customized bioengineered tissues and organs tailored to individual patient requirements, thus holding the promise to transform the treatment landscape for various diseases and injuries. The increasing prevalence of chronic diseases, including cardiovascular disorders and organ failures, serves as a key catalyst for market growth, as tissue engineering provides potential regenerative solutions. However, the market faces challenges due to substantial investment needs, including costly laboratory equipment, research materials, and extensive clinical trials, alongside regulatory hurdles that can impede development and approval processes. Despite these obstacles, advancements in stem cell research and technological innovations create a robust foundation for market expansion. Future opportunities lie in the realms of personalized and regenerative medicine therapies, which not only offer the potential to enhance patient care significantly but also revolutionize healthcare practices overall. As the tissue engineering market continues to mature, addressing the balance between high development costs and innovative solutions will be crucial for unlocking its full potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue Engineering market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tissue Engineering Market Segmental Analysis

Global Tissue Engineering Market is segmented by Product, Material, Application, End User, and Region. Based on Product, the market is segmented into Scaffolds (Synthetic Scaffolds, Biological Scaffolds (Collagen-Based Scaffolds, Hydrogel-Based Scaffolds, Stem Cell-Based Scaffolds, Other Biological Material-Based Scaffolds)), Tissue Grafts (Allografts, Autografts, Synthetic Grafts, Xenografts), Other Products. Based on Material, the market is segmented into Synthetic Materials, Biologically Derived Materials. Based on Application, the market is segmented into Orthopedic & Musculoskeletal Disorders, Dermatology & Wound Care, Dental Disorders, Cardiovascular Diseases, Other Applications. Based on End User, the market is segmented into Hospitals, Specialty Centers & Clinics, Ambulatory Surgery Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Tissue Engineering Market

The rising incidence of chronic diseases, including cardiovascular disorders, orthopedic conditions, and organ failures, significantly drives the global tissue engineering market. As the prevalence of these ailments increases, there is a growing demand for innovative therapeutic solutions that tissue engineering offers, such as the development and regeneration of tissues and organs. This field provides advanced treatment options, enhancing patient outcomes and addressing the limitations of traditional therapies. Consequently, healthcare providers and researchers are increasingly investing in tissue engineering technologies, which is catalyzing market growth and fostering innovations that aim to meet the urgent clinical needs of an aging population beset by chronic conditions.

Restraints in the Global Tissue Engineering Market

The global tissue engineering market encounters significant market restraints primarily due to stringent regulatory challenges that revolve around safety, efficacy, and ethical concerns associated with bioengineered tissues and cells. These regulations require extensive preclinical and clinical testing to ensure that products meet safety standards, which can lead to protracted approval timelines. Consequently, this not only hampers innovation and the introduction of novel therapies but also restricts the accessibility of existing tissue engineering solutions, as companies grapple with compliance costs and delays. Such regulatory hurdles ultimately inhibit market growth and deter investments, curtailing the proliferation of advanced tissue engineering technologies.

Market Trends of the Global Tissue Engineering Market

The Global Tissue Engineering market is witnessing a significant shift towards personalized medicine, driven by the increasing demand for customized healthcare solutions. As advancements in tissue engineering technology enable the creation of tailored tissues and organs that align with individual patient specifications, this trend is leading to enhanced treatment effectiveness and reduced rejection rates. The integration of precision medicine principles fosters a patient-centric approach, further bolstering market growth. As healthcare systems increasingly adopt personalized strategies, the tissue engineering sector is poised for innovation and expansion, reaffirming its critical role in addressing diverse patient needs and improving overall outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Pricing Analysis
• Value Chain Analysis
• Supply Chain Analysis
• Technology Analysis
• Patent Analysis
• Regulatory Landscape
• Customer & Buying Criteria Analysis

Tissue Engineering Market, By Product

• Market Overview
• Scaffolds
  • Synthetic Scaffolds
  • Biological Scaffolds
  • Collagen-Based Scaffolds
  • Hydrogel-Based Scaffolds
  • Stem Cell-Based Scaffolds
  • Other Biological Material-Based Scaffolds
• Tissue Grafts
  • Allografts
  • Autografts
  • Synthetic Grafts
  • Xenografts
• Other Products

Tissue Engineering Market, By Material

• Market Overview
• Synthetic Materials
• Biologically Derived Materials

Tissue Engineering Market, By Application

• Market Overview
• Orthopedic & Musculoskeletal Disorders
• Dermatology & Wound Care
• Dental Disorders
• Cardiovascular Diseases
• Other Applications

Tissue Engineering Market, By End User

• Market Overview
• Hospitals
• Specialty Centers & Clinics
• Ambulatory Surgery Centers

Tissue Engineering Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Organogenesis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MiMedx Group, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuVasive, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Collplant Biotechnologies Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sumitomo Pharma Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regrow Biosciences Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecnoss S.R.L.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra Lifesciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew Plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teijin Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Institut Straumann Ag
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TissueTech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Matricel Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vericel Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tegoscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tissue Regenix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments